USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market
Launch of Several Pipeline Oral Products Could Diminish the Market for Injectable Therapies
10-Nov-2014
North America
Market Research
NEC3-01-00-00-00
LS00130-NA-MR_16971
$3,950.00
Special Price $2,962.50 save 25 %
This market insight provides data for the global multiple sclerosis (MS) market. The analysis looks at MS pharmaceutical pipeline drugs that are currently in the market as well as any drugs that are in Phase III trials and pose a potential threat to competitors. It offers a competitive analysis of these drugs and the forecasted outcome and impact of each of these drugs. Injectable drugs dominate MS drugs currently in the market, but the launch of numerous oral pipeline products can shift this market in favor of oral drugs. The MS market is segmented into relapsing, remitting, secondary progressive, primary progressive, and progressive relapsing MS drugs.
Key Findings
Recent Market Developments
Recent Market Developments (continued)
Defining Healthcare Trends in the Future
Defining Healthcare Trends in the Future (continued)
Companies to Watch
Methodology and Scope
Introduction
Market Overview—Segmentation
Market Overview—Segmentation (continued)
Market Overview—Segmentation (continued)
Prevalence of MS in Major Market
Prevalence of MS in Major Market (continued)
Physician Guidelines to MS Therapy
Competitive Landscape—Count of Marketed and Pipeline Products
MS Therapeutics Competitive Landscape
Marketed Product Analysis
Marketed Product Analysis (continued)
Pipeline Analysis—Products in Clinical Development
Pipeline Analysis—Products in Clinical Development (continued)
Pipeline Analysis—Products in Clinical Development (continued)
Pipeline Analysis—Products in Clinical Development (continued)
Pipeline Analysis—Products in Clinical Development (continued)
Pipeline Analysis—Products in Clinical Development (continued)
Pipeline Analysis—Products in Clinical Development (continued)
Product Launch Timeline
Patent Expiration Timeline
Marketed Products Clinical Program—AUBAGIO (Teriflunomide)
Marketed Products Clinical Program—Plegridy
Marketed Products Clinical Program—Tysabri
Marketed Products Clinical Program—Tecfidera
Pipeline Products Clinical Program—Ocrelizumab, Ofatumumab
Pipeline Products Clinical Program—Lemtrada
Product Dashboard—Copaxone
Product Dashboard—Avonex (interferon beta-1a)
Product Dashboard—Betaseron/Extavia (interferon beta-1b)
Product Dashboard—Rebif (interferon beta-1a)
Product Dashboard—Tysabri (natalizumab)
Product Dashboard—Gilenya
Product Dashboard—Tecfidera (oral Glatiramer Fumarate)
Product Dashboard—Aubagio (Teriflunomide)
Product Dashboard—Plegridy (BIIB017) (pegylated interferon beta-1a)
Product Dashboard—Lemtrada/Campath 1G (Alemtuzumab)
Product Dashboard—Laquinimod
Product Dashboard—Zenapax (daclizumab)
Product Dashboard—Ocrelizumab
Product Dashboard—AB1010 (Masitinib)
Product Dashboard—Ofatumumab
Conclusions and Recommendations
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related industry research
06 Aug 2026 | Global | Technology Research
Decentralized Clinical Trials Powered by Blockchain and Digital Twins
This report examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical research. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of...
06 Aug 2026 | Global | Market Research
Machine Tools Sector, Global, 2023–2030
This study provides an in-depth understanding of the machine tools industry. It discusses the key trends and challenges faced by machine tool manufacturers, in addition to providing forecasts until 2030. The study provides a region-wise breakdown with discussions on key industries. Machine tool manu...
06 Aug 2026 | Global | Market Research
Top Trends Driving the Automotive Market, Global, 2026
Global light vehicle demand remained resilient in 2025, supported by the recovery of major automotive markets, strong APAC momentum, and the continued consumer shift toward electrified and utility-focused vehicles. This report evaluates how the global automotive industry is entering 2026 amid geopol...
05 Aug 2026 | Global | Frost Radar
Frost Radar™: Shop Floor-Centric Augmented Connected Worker Platforms, 2026
Manufacturers are confronting a skilled labor shortage. As they try to find a solution, augmented connected worker (ACW) platforms can become a key ally in training the new workforce and strengthening employee retention through comprehensive upskilling capabilities, skills management tools, and assi...
05 Aug 2026 | Global | Market Research
Material Trends and Dynamics in Battery Recycling, 2025–2032
Frost & Sullivan analyzes the global battery recycling market, focusing on the evolving lithium-ion battery (LIB) ecosystem.
The study explores the trends and dynamics shaping the battery recycling value chain, from battery production and usage to collection, pre-processing, material recovery...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Aish Vivekanadan |
| WIP Number | NEC3-01-00-00-00 |
| Is Prebook | No |